Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway

Outcomes have not improved for metastatic osteosarcoma for several decades. In part, this failure to develop better therapies stems from a lack of understanding of osteosarcoma biology, given the rarity of the disease and the high genetic heterogeneity at the time of diagnosis. We report here the su...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Oncotarget
Κύριοι συγγραφείς: VanCleave, Ashley, Palmer, Mykayla, Fang, Fang, Torres, Haydee, Rodezno, Tania, Li, Qilin, Fuglsby, Kirby, Evans, Claire, Afeworki, Yohannes, Ross, Alan, Rao, Pulivarthi, Leiferman, Patricia, Zheng, Siyuan, Houghton, Peter, Tao, Jianning
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Impact Journals LLC 2020
Θέματα:
Research Paper
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7343631/
https://ncbi.nlm.nih.gov/pubmed/32676162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27611
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια